Products
Data
Feature
Plans
Request Demo
Sign Up for Free
Blog
Valuable Targets
Advanced Tech.
Recent blog posts
Latest Hotspot
8 min read
NCT07528716 Trastuzumab Rezetecan Breast Cancer Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
13 August 2026
NCT07528716 clinical trial report covering Trastuzumab Rezetecan, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
CTR20261025 Lofacimig Thromboembolism Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
13 August 2026
CTR20261025 clinical trial report covering Lofacimig, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07528027 Safiglipron Hypertension Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
13 August 2026
NCT07528027 clinical trial report covering Safiglipron, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07529262 Aspirin Hepatocellular Carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
13 August 2026
NCT07529262 clinical trial report covering Aspirin, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07526974 Resveratrol/Curcumin Subcutaneous fat disorder Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
13 August 2026
NCT07526974 clinical trial report covering Resveratrol/Curcumin, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07526987 Minocycline Hydrochloride Acute Ischemic Stroke Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
13 August 2026
NCT07526987 clinical trial report covering Minocycline Hydrochloride, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07529977 Minoxidil Androgenetic Alopecia Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
13 August 2026
NCT07529977 clinical trial report covering Minoxidil, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
CTR20261373 Recombinant Zoster Vaccine(CHO Cell)(Kangtai) Herpes Zoster Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
13 August 2026
CTR20261373 clinical trial report covering Recombinant Zoster Vaccine(CHO Cell)(Kangtai), Phase 3, endpoints, sponsor, geography, readout timing and develo
Read →
Latest Hotspot
8 min read
NCT07530146 Propofol/Ketamine Hydrochloride Critical Illness Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
13 August 2026
NCT07530146 clinical trial report covering Propofol/Ketamine Hydrochloride, Phase 3, endpoints, sponsor, geography, readout timing and development white sp
Read →
Latest Hotspot
8 min read
CTR20261451 Epsametostat Peripheral T-Cell Lymphoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
13 August 2026
CTR20261451 clinical trial report covering Epsametostat, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07530640 Atorvastatin Calcium Coronary Artery Disease Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
13 August 2026
NCT07530640 clinical trial report covering Atorvastatin Calcium, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07530367 Tofacitinib Citrate Pustulosis of Palms and Soles Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
13 August 2026
NCT07530367 clinical trial report covering Tofacitinib Citrate, Phase 3, endpoints, sponsor, geography, readout timing and development white space.
Read →
<
1
<<
247
248
249
250
251
>>
1222
>